Clinical Trial Update: Effects of Ezetimibe, Simvastatin, and Vytorin on Reducing L5 a Subfraction of LDL in Patients With Metabolic Syndrome. [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effects of ezetimibe, simvastatin, and Vytorin on a specific LDL subfraction in patients with metabolic syndrome; results posted af…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Vytorin (ezetimibe/simvastatin)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Metabolic Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2023-11-30